Disposition of 120000 shares by Hollander David of Revance subject to Rule 16b-3

RVNC Stock  USD 3.61  0.17  4.50%   
About 68% of Revance's investor base is looking to short. The analysis of overall sentiment of trading Revance stock suggests that many investors are alarmed at this time. The current market sentiment, together with Revance's historical and current headlines, can help investors time the market. In addition, many technical investors use Revance stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Revance Officer: Cmo & Global Therapeutics Lead. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at finance.yahoo.com
Yahoo News
  
Revance insider trading alert for disposition of performance stock units by Hollander David, Officer: Cmo & Global Therapeutics Lead, on 3rd of October 2024. This event was filed by Revance with SEC on 2025-02-15. Initial filing of beneficial ownership - SEC Form 3

Revance Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Revance can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Revance Fundamental Analysis

We analyze Revance's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revance using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revance based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Insiders

Shares Owned By Insiders Comparative Analysis

Revance is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Revance Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Revance stock to make a market-neutral strategy. Peer analysis of Revance could also be used in its relative valuation, which is a method of valuing Revance by comparing valuation metrics with similar companies.

Peers

Revance Related Equities

DMACDiaMedica Therapeutics   8.64   
0%
100.0%
PLRXPliant Therapeutics   2.00   
0%
23.0%
STOKStoke Therapeutics   1.68   
0%
19.0%
DAWNDay One   1.53   
0%
17.0%
BPMCBlueprint Medicines   1.35   
0%
15.0%
VTYXVentyx Biosciences   1.13   
0%
13.0%
NUVLNuvalent   0.08   
1.0%
0%
AKROAkero Therapeutics   0.22   
2.0%
0%
IMCRImmunocore Holdings   0.27   
3.0%
0%
APLSApellis Pharmaceuticals   0.62   
7.0%
0%
MDGLMadrigal Pharmaceuticals   0.98   
11.0%
0%
ACLXArcellx   1.12   
12.0%
0%
TERNTerns Pharmaceuticals   1.58   
18.0%
0%
ETNB89bio   1.64   
18.0%
0%
AMLXAmylyx Pharmaceuticals   3.48   
40.0%
0%

Complementary Tools for Revance Stock analysis

When running Revance's price analysis, check to measure Revance's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revance is operating at the current time. Most of Revance's value examination focuses on studying past and present price action to predict the probability of Revance's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revance's price. Additionally, you may evaluate how the addition of Revance to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stocks Directory
Find actively traded stocks across global markets